CCRAS showcases groundbreaking research at ‘Health Care Next 2024′

The Central Council for Research in Ayurvedic Sciences (CCRAS) has unveiled its pioneering achievements in Ayurvedic drug development at the prestigious international conference ‘Health Care Next 2024,’ held at GITAM Deemed to be University School of Pharmacy. The event convened leading experts to engage in insightful discussions and propel advancements in innovative healthcare solutions.
Dr. G. Babu, Director of CARI, illuminated CCRAS’s pivotal role in formulating essential Ayurvedic medicines like Ayush 64, 82, 56, Manas, and Rasayana. He elaborated on the widespread adoption of Ayush 64 as a prophylactic drug during the Covid-19 pandemic, and outlined the ongoing research initiatives encompassing diverse disciplines within CCRAS Institutes. Dr. Babu expressed fervent interest in forging collaborative efforts with GITAM’s pharmacy researchers to spearhead the development of novel drugs. He commended CARI in Kolkata for its position as the frontrunner among AYUSH institutes, housing NABH-accredited hospitals, NABL-accredited testing laboratories, an Ayurvedic drug manufacturing unit, and a state-of-the-art research centre.
Dr. A. Ramakrishna, Deputy Drugs Controller (India), shed light on the Indian pharmaceutical industry’s impressive growth trajectory, currently valued at $53 billion and supplying medications to over 200 countries. He accentuated the crucial role of innovation and urged university researchers to prioritise clinical research, despite the challenges posed by recent lockdowns and public health crises. The inaugural session was attended by Prof. B. Geetanjali, Pro Vice-Chancellor, GIMSR, Prof. Jagattaran Das, Dean, School of Pharmacy, Prof. S. Raja, Principal, and conference convenors Dr. Partha Raoy and Dr. P. Naresh.